Bioinformatics Market: 25% CAGR Over Next 6 Years

The report below (originally produced by Transparency Market Research and reported / summarized by FierceBiotech IT) confirms what we already know from our cloud computing and colocation customers: bioinformatics is big.
It also underscores why we launched AIS ClearCompute: massive growth, massive scale, massive flexibility, massive awesomeness.
Let us know if you’d like to know more about how AIS ClearCompute fits into the sequencing space.
Emphasis in red added by me.
Brian Wood, VP Marketing

Study: Genomics, Outsourcing Fuel Bioinformatics

The bioinformatics market is on track for sizable growth over the next 6 years, with heavy demand from researchers in genomics and biopharma, according to a new report from Transparency Market Research. The market is expected to jump from $2.3 billion in 2012 to $9.1 billion in 2018, according to the firm’s findings, and the massive growth points to a market that is firing on many cylinders.
The big numbers may not come as a surprise. Scientists rely heavily on bioinformatics tools to organize fast-growing amounts of complex biological information nowadays. And Transparency points to demand from developers of drugs, diagnostics and agricultural products, as well as from other researchers as key drivers of demand for bioinformatics in the coming years.
Once a bit of a backwater of new business activity, bioinformatics is the focus of a bevy of software providers that have emerged over the past several years, many of them hellbent on enabling better ways of slicing and dicing genomics data to aid life sciences researchers. Illumina ($ILMN), Life Technologies ($LIFE), PerkinElmer ($PKI) and other major genomics players have boosted their stakes in bioinformatics, investing in the field amid expectations for analytics software to have broad impacts on healthcare.
Life Technologies, for instance, last month acquired cancer bioinformatics outfit Compendia Bioscience as the buyer sought to gain technology to beef up its offerings in the diagnostics market. Illumina, the largest provider of DNA sequencing systems, has set up BaseSpace to provide an online store of informatics tools that its customers can use to analyze genomic data from its sequencers. And PerkinElmer has partnered with TIBCO Spotfire to build up its analytics capabilities.
Transparency foresees growth from companies that tackle bioinformatics from pharma companies that outsource those activities as well. And if the firm’s lofty market growth figures are on target, a bunch of these major movers and shakers are poised to make a lot of money.

Global Bioinformatics Market is Expected to Reach $9.1B in 2018

ALBANY, New York, November 28, 2012 — /PRNewswire/ — According to a new market report “Bioinformatics Market – Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012  2018,” published by Transparency Market Research (, the global bioinformatics market is estimated to reach market size worth USD 9.1 Billion in 2018. The market is forecasted to record double digit growth, with highest revenue contribution from the bioinformatics platforms segment.

The global bioinformatics market, estimated at USD 2.3 billion in 2012 is forecasted to reach a market size of USD 9.1 billion in 2018, at a CAGR of 25.4% from 2012 – 2018. The market growth is driven by rise in applications across various industries. The key contribution to the market demand is from fields such as agriculture biotechnology, pharmaceutical research and development, medical and clinical diagnostics, and other life-sciences related industries.
The bioinformatics platform holds the largest market share and is estimated to account for nearly 50% of the market revenue. The services market currently holds a relatively smaller market share, however is expected to increase considerably over the forecast period. The bioinformatics platform segment is the fastest growing market and is expected to contribute 54% of the total market growth during the same period.

The demand across genomics and wide application in the medical and biological information sector is driving the demand for bioinformatics platforms and services in the global market. The research outsourcing by pharmaceutical giants in the fields involving bioinformatics content is a significant driver of the global bioinformatics market. These companies in efforts to reduce time and cost on R&D activities involved in the development of novel drugs and new applications for existing drugs, are looking for outsourcing services for bioinformatics knowledge and management tools, platforms, and services.
Among the regional markets, North America holds the largest share; however, is forecasted to be succeeded by Europe as the leading market share holder in 2018, due to fast growth shown by major European markets such as Germany and U.K. Europe is forecasted to be the fastest growing region, with growth mainly driven by rising government support for R&D activities in the region. The bioinformatics services market in Europe and North America is well developed and organized whereas it is still in initial growth stage in emerging markets of Asia Pacific region.
The report analyzes the global bioinformatics market growth across various segments such as knowledge management tools, platforms, and services. The in-depth analysis includes analysis of sub-segments up to three levels, with cross sectional analysis on the basis of geographical and regional market size and forecasts. The cross-sectional analysis of the global bioinformatics market based on applications further provides market growth potential across various end user industries. The segments considered on the basis of application are – molecular medicine, gene therapy, drug development and preventive medicine.